Deferasirox Tablet, For Suspension
Product Images NDC 69452-160

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 69452-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure0001

A bar graph showing the change in liver iron content (mg Fe/g dry weight) and serum ferritin (mcg/L) across different doses of Deferasirox (5, 10, 20, 30 mg/kg/day). Liver iron content changes are represented by white bars and serum ferritin changes by black bars, with corresponding sample sizes noted for each dose group.*

FDA Label Image

Image001

Label for Deferasirox Tablets for Oral Suspension, 125 mg per tablet. The label includes directions not to chew or swallow whole and states that tablets must be dispersed in water, orange, or apple juice prior to ingestion. It is distributed by Bionpharma Inc., Princeton, NJ, and comes in a bottle of 30 tablets. Storage instructions and a barcode are also displayed.*

FDA Label Image

Image002

Deferasirox Tablets for Oral Suspension 250 mg per tablet in a package containing 30 tablets. The label instructs that tablets must be dispersed in water, orange, or apple juice prior to ingestion and not swallowed whole. The labeler is Bionpharma Inc., located in Princeton, NJ. Storage instructions and a barcode are also visible.*

FDA Label Image

Image003

Label for Deferasirox Tablets for Oral Suspension, 500 mg per tablet, distributed by Bionpharma Inc. The label includes warnings to not chew or swallow tablets whole and instructions to disperse tablets in water or juice prior to ingestion. Package contains 30 tablets. Storage instructions and barcode are also visible.*

FDA Label Image

Molecular Structure (Molecularstructure)

Chemical structure of deferasirox, the active ingredient in Deferasirox tablets for suspension. The structure shows multiple aromatic rings and functional groups characteristic of deferasirox.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.